Kerecis, a leader in the use of fish skin and fatty acids for tissue regeneration, has announced the publication of significant study results in the New England Journal of Medicine…
Bristol Myers Squibb (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab) for adult patients with resectable non-small cell lung cancer (NSCLC) with…
OS Therapies (NYSE American: OSTX) announced today that the last patient (Patient #41) enrolled in the AOST-2121 clinical trial (NCT04974008) for OST-HER2 in recurrent, resected osteosarcoma has completed their final…
Fresenius Kabi, part of Fresenius and specializing in biopharmaceuticals, clinical nutrition, and medical technologies, along with Formycon AG, an independent developer of biosimilars, has announced FDA approval for Otulfi™ (ustekinumab-aauz),…
Repare Therapeutics Inc. (Nasdaq: RPTX), a clinical-stage precision oncology company, today shared data showcasing the clinical benefits of camonsertib, a promising oral small molecule ATR inhibitor, used in combination with…
CVS Health® (NYSE: CVS) is proactively preparing for the impending landfall of Hurricane Helene in Florida. The company prioritizes the health and safety of its customers, members, and employees, aiming…
Bristol Myers Squibb (NYSE:BMY) has announced promising results from the Phase 3b/4 PSORIATYK SCALP trial, which assessed the efficacy of Sotyktu (deucravacitinib) in treating patients with moderate-to-severe scalp psoriasis, including…
Next Health, a leader in proactive healthcare, is set to open two health optimization and longevity centers in Tampa and St. Petersburg under an area development agreement. This move comes…
Perspectum recently announced two published research studies that offer hope to those with metabolic dysfunction-associated steatohepatitis (MASH). The studies validate the effectiveness of quantitative MRI imaging as a potential alternative…
The Bioscience Association Manitoba (BAM) marked Global Biotech Week with an official proclamation at the Manitoba Legislative Building. The event gathered 80 Manitoba students, industry leaders, and government officials to…
NULIFE GreenTech, a leader in carbon removal solutions, has been chosen by Frontier for its 2024 prepurchase cycle. Frontier, established by major companies like Stripe, Alphabet, Shopify, Meta, and McKinsey…
Fathom, a leader in autonomous medical coding, announced today that its technology received 100% high customer satisfaction and unanimous validation of its 90%+ automation rates in a recent KLAS Research…